查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1573089

COPD/氣喘設備市場：按產品類型、應用、最終用戶、分銷管道分類的全球預測 - 2025-2030

COPD & Asthma Devices Market by Product Type (Accessories, Inhalers, Nebulizers), Application (Asthma, Chronic Obstructive Pulmonary Disease (COPD)), End-User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，慢性阻塞性肺病和氣喘設備市場價值為353.3億美元，預計2024年將達到374.5億美元，複合年成長率為5.93%，到2030年將達到529億美元。

慢性阻塞性肺病和氣喘設備市場包括醫療設備和設計用於診斷、治療和管理慢性阻塞性肺病（COPD）和氣喘的設備。這包括吸入器、霧化器、氧氣濃縮機、肺活量測定裝置等，這些在臨床和家庭環境中都是必不可少的。這些設備的需求源於由於污染、吸煙和人口老化等因素導致的呼吸道疾病的日益普及。這些設備對於有效給藥、監測呼吸狀態和改善患者生活品質至關重要。人們對呼吸系統健康的認知不斷提高以及醫療技術的進步正在推動已開發市場和新興市場的需求。關鍵的成長要素包括智慧吸入器和攜帶式霧化器等技術創新、醫療保健支出增加以及促進呼吸護理的政府支持政策。最新的機會在於數位醫療技術的整合，透過應用程式和物聯網設備增強患者的依從性和監測。製造商可以利用這一點，投資研發，為精通科技的患者創造更容易使用、連結性更強的設備。然而，這個市場面臨先進設備高成本、監管核准嚴格、低收入地區准入受限等挑戰。此外，醫療保健基礎設施的差異可能會阻礙新興國家的市場成長。為了克服這些障礙，注重創新的公司應考慮具有成本效益的製造程序，並尋求夥伴關係關係以擴大市場範圍。此外，研究應旨在提高設備功效並減少副作用，以滿足患者的特定需求。市場競爭仍然激烈，我們看到企業之間存在整合趨勢，旨在透過併購擴大產品系列。總體而言，該行業不斷發展，以患者為中心的數位創新有廣闊的開拓，為慢性阻塞性肺病和氣喘治療設備市場提供了成長機會。

主要市場統計
基準年[2023] 353.3億美元
預測年份 [2024] 374.5億美元
預測年份 [2030] 529億美元
複合年成長率（%） 5.93%

市場動態：針對快速發展的慢性阻塞性肺病和氣喘設備市場所揭示的關鍵市場見解

供需的動態交互作用正在改變慢性阻塞性肺病和氣喘設備市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 支持呼吸系統疾病管理和治療的政府措施和政策
    • 新興市場透過改善醫療服務為呼吸設備製造商提供了新的機會
    • 透過使用者友善的攜帶式設備設計提高患者對呼吸治療的依從性
    • 環境污染加劇導致呼吸道疾病惡化，治療設備的需求增加
  • 市場限制因素
    • 慢性阻塞性肺病和氣喘設備製造缺乏標準化影響產品一致性
    • 醫療保健提供者在慢性阻塞性肺病和氣喘治療設備的最新進展方面面臨的教育挑戰
  • 市場機會
    • 慢性阻塞性肺病和氣喘治療方案中個人化醫療方法的興起
    • 加強病患教育和自我管理計畫以減少氣喘住院率
    • 一種創新的藥物傳遞系統，可提高慢性阻塞性肺病治療的藥物順從性
  • 市場挑戰
    • 確保患者堅持用藥和遵守規定治療方法的複雜性
    • 農村和服務欠缺地區的醫療服務有限

波特五力：駕馭慢性阻塞性肺病/氣喘設備市場的策略工具

波特的五力是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 COPD/氣喘設備市場的外部影響

外部宏觀環境因素在塑造慢性阻塞性肺病和氣喘設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解慢性阻塞性肺病/氣喘設備市場的競爭格局

對慢性阻塞性肺病和氣喘設備市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣 COPD 與氣喘設備市場供應商的績效評估

FPNV定位矩陣是評估COPD/氣喘設備市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，描繪慢性阻塞性肺病和氣喘設備市場的成功之路

對於旨在加強其全球市場影響力的公司來說，對慢性阻塞性肺病和氣喘設備市場進行策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 支持呼吸系統疾病管理和治療的政府措施和政策
      • 新興市場透過增加醫療保健機會為呼吸系統製造商創造新機會
      • 易於使用的可攜式設備設計提高了患者對呼吸治療的依從性
      • 環境污染加劇導致呼吸道疾病惡化，增加對治療設備的需求
    • 抑制因素
      • 慢性阻塞性肺病和氣喘設備製造缺乏標準化影響產品一致性
      • 對醫護人員進行有關慢性阻塞性肺病和氣喘治療設備最新進展的教育面臨的挑戰
    • 機會
      • 慢性阻塞性肺病和氣喘治療通訊協定中個人化醫療方法的興起
      • 加強病患教育和自我管理計劃，以減少與氣喘相關的住院治療
      • 創新的藥物傳遞系統，可提高慢性阻塞性肺病治療的用藥依從性
    • 任務
      • 確保患者依從性和遵守規定治療計畫的併發症
      • 農村和服務欠缺地區獲得醫療保健的機會有限
  • 市場區隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 COPD/氣喘設備市場：依產品類型

  • 配件
    • 致動器
    • 乾粉吸入器轉子蓋和藥筒
    • 墊片
  • 吸入器
    • 乾粉吸入器 (DPI)
    • 定量噴霧吸入器(MDI)
    • 緩霧吸入器
  • 噴霧器
    • 噴射霧化器
    • 網狀霧化器
    • 超音波霧化器

第 7 章 COPD/氣喘設備市場：依應用分類

  • 氣喘
    • 過敏性氣喘
    • 運動誘發的氣喘
    • 非過敏性氣喘
  • 慢性阻塞性肺病（COPD）
    • 慢性支氣管炎
    • 氣腫

第 8 章 COPD/氣喘設備市場：依最終使用者分類

  • 門診手術中心
  • 家庭護理設置
  • 醫院/診所
  • 專科診所

第 9 章 COPD/氣喘設備市場：依通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第10章北美和南美的慢性阻塞性肺病/氣喘設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區慢性阻塞性肺病/氣喘設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的慢性阻塞性肺病/氣喘設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-535C62918B2C

The COPD & Asthma Devices Market was valued at USD 35.33 billion in 2023, expected to reach USD 37.45 billion in 2024, and is projected to grow at a CAGR of 5.93%, to USD 52.90 billion by 2030.

The COPD and asthma devices market encompasses medical devices and equipment designed for the diagnosis, treatment, and management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. This includes inhalers, nebulizers, oxygen concentrators, and spirometry devices, which are essential for clinical and home-based settings. The necessity of these devices stems from the increasing prevalence of respiratory diseases due to factors like pollution, smoking, and an aging population. These devices are pivotal in efficiently administering medications, monitoring respiratory conditions, and improving the quality of life for patients. The growing awareness about respiratory health and advancements in medical technology drive demand in both developed and developing markets. Key growth factors include technological innovations such as smart inhalers and portable nebulizers, increasing healthcare expenditure, and supportive government policies promoting respiratory care. Latest opportunities lie in the integration of digital health technologies, which offer enhanced patient adherence and monitoring through apps and IoT-enabled devices. Manufacturers can capitalize on this by investing in R&D to create more user-friendly and connected devices that cater to tech-savvy patients. However, the market faces challenges such as high costs of advanced devices, stringent regulatory approvals, and limited access in lower-income regions. Additionally, the disparity in healthcare infrastructure could hinder market growth in emerging economies. Companies focusing on innovation must consider cost-effective manufacturing processes and seek partnerships to expand market reach to overcome these barriers. Research should also target enhancing device effectiveness and reducing side effects to meet patient-specific needs. The market remains competitive, with consolidation trends as companies seek to expand their product portfolios through mergers and acquisitions. Overall, the industry continues evolving, with ample scope for development in patient-centered and digital innovations, which present lucrative opportunities for growth in the COPD and asthma devices market.

KEY MARKET STATISTICS
Base Year [2023] USD 35.33 billion
Estimated Year [2024] USD 37.45 billion
Forecast Year [2030] USD 52.90 billion
CAGR (%) 5.93%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COPD & Asthma Devices Market

The COPD & Asthma Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government initiatives and policies supporting respiratory disease management and treatment
    • Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
    • Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
    • Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
  • Market Restraints
    • Lack of standardization in COPD & asthma device manufacturing affecting product consistency
    • Challenges in educating healthcare providers about the latest COPD & asthma device advancements
  • Market Opportunities
    • Rise of personalized medicine approaches in COPD and asthma treatment protocols
    • Growth in patient education and self-management programs to reduce asthma-related hospitalizations
    • Innovative drug delivery systems enhancing medication adherence in COPD treatments
  • Market Challenges
    • Complications in ensuring patient adherence and compliance with prescribed treatment regimens
    • Limited healthcare access in rural and underserved areas

Porter's Five Forces: A Strategic Tool for Navigating the COPD & Asthma Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COPD & Asthma Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COPD & Asthma Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COPD & Asthma Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COPD & Asthma Devices Market

A detailed market share analysis in the COPD & Asthma Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COPD & Asthma Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COPD & Asthma Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COPD & Asthma Devices Market

A strategic analysis of the COPD & Asthma Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COPD & Asthma Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Health Care, Aerogen, Air Liquide Healthcare, Becton, Dickinson and Company, Chart Industries, Drive DeVilbiss Healthcare, Fisher & Paykel Healthcare, Getinge, GF Health Products, Inc., Hamilton Medical, Invacare Corporation, Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, PARI Medical Holding, ResMed, Smiths Medical, SunMed, and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the COPD & Asthma Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Accessories, Inhalers, and Nebulizers. The Accessories is further studied across Actuators, Dry Powder Inhaler Rotacaps & Cartridges, and Spacers. The Inhalers is further studied across Dry Powder Inhalers (DPI), Metered-Dose Inhalers (MDI), and Soft Mist Inhalers. The Nebulizers is further studied across Jet Nebulizers, Mesh Nebulizers, and Ultrasonic Nebulizers.
  • Based on Application, market is studied across Asthma and Chronic Obstructive Pulmonary Disease (COPD). The Asthma is further studied across Allergic Asthma, Exercise-Induced Asthma, and Non-Allergic Asthma. The Chronic Obstructive Pulmonary Disease (COPD) is further studied across Chronic Bronchitis and Emphysema.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Homecare Settings, Hospitals & Clinics, and Specialty Clinics.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government initiatives and policies supporting respiratory disease management and treatment
      • 5.1.1.2. Emerging markets creating new opportunities for respiratory device manufacturers through enhanced healthcare access
      • 5.1.1.3. Improved patient adherence to respiratory therapies driven by user-friendly and portable device designs
      • 5.1.1.4. Rising environmental pollution exacerbating respiratory conditions and increasing demand for treatment devices
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of standardization in COPD & asthma device manufacturing affecting product consistency
      • 5.1.2.2. Challenges in educating healthcare providers about the latest COPD & asthma device advancements
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise of personalized medicine approaches in COPD and asthma treatment protocols
      • 5.1.3.2. Growth in patient education and self-management programs to reduce asthma-related hospitalizations
      • 5.1.3.3. Innovative drug delivery systems enhancing medication adherence in COPD treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Complications in ensuring patient adherence and compliance with prescribed treatment regimens
      • 5.1.4.2. Limited healthcare access in rural and underserved areas
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. COPD & Asthma Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessories
    • 6.2.1. Actuators
    • 6.2.2. Dry Powder Inhaler Rotacaps & Cartridges
    • 6.2.3. Spacers
  • 6.3. Inhalers
    • 6.3.1. Dry Powder Inhalers (DPI)
    • 6.3.2. Metered-Dose Inhalers (MDI)
    • 6.3.3. Soft Mist Inhalers
  • 6.4. Nebulizers
    • 6.4.1. Jet Nebulizers
    • 6.4.2. Mesh Nebulizers
    • 6.4.3. Ultrasonic Nebulizers

7. COPD & Asthma Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Asthma
    • 7.2.1. Allergic Asthma
    • 7.2.2. Exercise-Induced Asthma
    • 7.2.3. Non-Allergic Asthma
  • 7.3. Chronic Obstructive Pulmonary Disease (COPD)
    • 7.3.1. Chronic Bronchitis
    • 7.3.2. Emphysema

8. COPD & Asthma Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Homecare Settings
  • 8.4. Hospitals & Clinics
  • 8.5. Specialty Clinics

9. COPD & Asthma Devices Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas COPD & Asthma Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific COPD & Asthma Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa COPD & Asthma Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

LIST OF FIGURES

  • FIGURE 1. COPD & ASTHMA DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. COPD & ASTHMA DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. COPD & ASTHMA DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. COPD & ASTHMA DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COPD & ASTHMA DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COPD & ASTHMA DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACTUATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALER ROTACAPS & CARTRIDGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPACERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DRY POWDER INHALERS (DPI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY METERED-DOSE INHALERS (MDI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EXERCISE-INDUCED ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY NON-ALLERGIC ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COPD & ASTHMA DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 77. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CANADA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MEXICO COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED STATES COPD & ASTHMA DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. AUSTRALIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 124. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. CHINA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 133. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. INDONESIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. JAPAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. MALAYSIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. PHILIPPINES COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. SINGAPORE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. SOUTH KOREA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. TAIWAN COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. THAILAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. VIETNAM COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA COPD & ASTHMA DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. DENMARK COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. EGYPT COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. FINLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. FRANCE COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. GERMANY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. ISRAEL COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 283. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 284. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 286. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 287. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. ITALY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 289. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 291. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 292. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 293. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 295. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 296. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. NETHERLANDS COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 298. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 300. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 301. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 302. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 303. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 304. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 305. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. NIGERIA COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 307. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 308. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 309. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 310. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 311. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 313. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 314. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 315. NORWAY COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 316. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 317. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 318. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 319. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 320. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 322. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 323. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 324. POLAND COPD & ASTHMA DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 325. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 326. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
  • TABLE 327. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
  • TABLE 328. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
  • TABLE 329. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 330. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
  • TABLE 331. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), 2018-2030 (USD MILLION)
  • TABLE 332. QATAR COPD & ASTHMA DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 333. QATAR COPD